KLK6 and Alzheimer disease: Whereas the data presented here supports that of an earlier study observing increased levels of KLK6 in the plasma of AD patients [19], the increase in expression of GJB1 (which encodes for connexin-32) in the AD group contradicts other studies that suggest a decrease in connexins in AD mouse models [20].